Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on September 11, 2019. The filing reports corporate governance changes effective immediately on that date, specifically regarding the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Appointment of Director: The Board appointed Hersh Kozlov as a new member. Mr. Kozlov is the managing partner of the Cherry Hill, NJ office of Duane Morris and serves on the board of The Bancorp, Inc. He is considered independent under NASDAQ rules and will participate in standard non-employee director compensation arrangements.
- Resignation of Director: Steven M. Cohen resigned from the Board. The Company stated the resignation was not the result of any dispute or disagreement regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary on business outlook, financial guidance, or specific risk factors. It confirms there are no undisclosed arrangements or transactions with the new director reportable under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the independence status of the newly appointed director, Hersh Kozlov, per NASDAQ listing rules.
- Confirm the absence of any undisclosed disputes surrounding the resignation of Steven M. Cohen.
- Review the Company's 2019 annual proxy statement (filed March 15, 2019) for details on the non-employee director compensation arrangements applicable to Mr. Kozlov.